Kirk Sean 4
4 · Emergent BioSolutions Inc. · Filed Feb 27, 2020
Insider Transaction Report
Form 4
Kirk Sean
EVP, Manufacturing & Tech Ops
Transactions
- Award
Common Stock
2020-02-25+3,662→ 17,266 total - Award
Common Stock
2020-02-25+3,662→ 20,928 total - Tax Payment
Common Stock
2020-02-26$59.91/sh−382$22,886→ 20,546 total - Tax Payment
Common Stock
2020-02-26$59.91/sh−277$16,595→ 20,269 total - Award
Employee Stock Options (Right to Buy)
2020-02-25$61.44/sh+14,648$899,973→ 37,668 totalExercise: $61.44Exp: 2027-02-24→ Common Stock (14,648 underlying) - Tax Payment
Common Stock
2020-02-27$58.42/sh−608$35,519→ 19,661 total
Footnotes (4)
- [F1]These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
- [F2]Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue for the 2020 - 2022 fiscal years, as certified by the Compensation Committee following the performance period.
- [F3]Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated.
- [F4]Vests in three equal installments beginning on the day prior to the anniversary date of the grant.